Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to evaluate the safety, tolerability, and drug levels of BMS-986454 in participants with rheumatoid arthritis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BMS-986454

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 1 | Status: RECRUITING